Furthermore, it has been reported that neutralization of secreted FABP4 with an antibody to FABP4 can be a novel strategy for treatment of insulin resistance, type 2 diabetes mellitus, atherosclerosis and vascular injury8,11,12. Here, FABP4 is linked to type 2 diabetes mellitus.